D. E. Shaw & Co., Inc. - ADAMIS PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2018$34,00010,6110.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Capital CS Group, LLC 75,669$38,0000.04%
Founders Capital Management 18,000$9,0000.01%
Verdence Capital Advisors LLC 58,382$29,0000.00%
WOLFF WIESE MAGANA LLC 10,740$5,0000.00%
TWO SIGMA SECURITIES, LLC 93,669$47,0000.00%
Affinity Capital Advisors, LLC 13,180$7,0000.00%
Tower Research Capital LLC (TRC) 171,928$86,0000.00%
B. Riley Wealth Advisors, Inc. 25,210$13,0000.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 100,000$50,0000.00%
MGO ONE SEVEN LLC 10,615$5,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders